Albuterol 2.5mg / Ipratropium 0.75mg /Budesonide 0.5mg
Lack of Processing Controls
Yes — there is an active recall. 6 ongoing FDA recalls mention Albuterol (42 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Albuterol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls
Lack of Processing Controls.
Failed Impurities/Degradation Specifications: high out of specification results for related compound D.
Defective Delivery System: Elevated number of units with out of specification results for leak rate
Defective Delivery System: Elevated number of units with out of specification results for leak rate.
Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.
Presence of Foreign Substance; presence of black particles describes generically as cellulose-based bundles of brown fibrous material.
Defective Delivery System: Some canisters may not contain sufficient propellant to deliver the labeled claim of 200 actuations through the end of shelf life.
Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process
Defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray.
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Lack of Assurance of Sterility: Nephron Pharmaceuticals Corporation conducted a routine periodic aseptic process simulation and discovered bacterial growth in a number of media fill vials, exceeding the allowable limit.
Labeling: Label Mixup: ALBUTEROL SULFATE ER, Tablet, 4 mg may have potentially been mislabeled as one of the following drugs: SIMVASTATIN, Tablet, 20 mg, NDC 16714068303, Pedigree: W003580, EXP: 6/24/2014.
Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.
Lack of Assurance of Sterility
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.